At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023

At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023 examines a range of both at-home tests and home collection tests. The At-Home in vitro diagnostic (IVD) testing market is comprised of IVD tests that can be purchased at the local store or on the Internet where the patient gathers the specimen and results are displayed usually within minutes. Generally, these are lateral flow technology or dip stick methods. 

Meanwhile, the global Home IVD testing market is a growing market with much potential. The Home Collection IVD testing market is comprised of testing kits that are obtained from the local pharmacy or internet and sent to the patient's home. The patient collects the specimen, puts it into a collection container and sends it to the laboratory for testing. Results are sent back to the patient and/or referring physician.

This report covers the At-Home and Home testing markets by segmenting them into several broad areas including:

• Cholesterol
• Drugs of Abuse
• Fecal Occult Blood
• Glucose/ HbA1c including CGM
• Infectious Disease
  • COVID-19 / + Flu + RSV
  • HIV
• Pregnancy and Fertility
• Rapid Coagulation
• Genetic (excluding ancestry genetic testing)

The base year for data featured in the report was 2022. Data are provided for 2022 and 2027 with compound annual growth rates (CAGRs) for 2022 and 2027. Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, EMEA, Asia-Pacific and Rest of World for 2019-2022.  The forecasted market analysis for 2022-2027 was largely based on demographic trends, new developments, innovative technology and global expansion.